Evidence map›Paper›PMID 10510459›Full record

ArticleBritish journal of pharmacology1999

Regulation of cyclic AMP by extracellular ATP in cultured brain capillary endothelial cells.

Z Anwar, J L Albert, S E Gubby, J P Boyle, J A Roberts, T E Webb, M R Boarder

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Purinergic Regulation of Endothelial Barrier Function.International journal of molecular sciences · 2021
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Z AnwarDepartment of Cell Physiology and Pharmacology, University of Leicester, Medical Sciences Building, P.O. Box 138, University Road, Leicester LE1 9HN.
J L Albert
S E Gubby
J P Boyle
J A Roberts
T E Webb
M R Boarder
University of Leicester · GBUniversity College London · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

1 In primary unpassaged rat brain capillary endothelial cell cultures (RBECs), using reverse-transcriptase PCR with primers specific for P2Y receptor subtypes, we detected mRNA for P2Y2, P2Y4 and P2Y6, but not P2Y1 receptors. 2 None of the various nucleotides tested reduced forskolin elevated cyclic AMP levels in RBECs. ATP and ATPgammaS, as well as adenosine, enhanced cyclic AMP accumulation in the presence of forskolin. 3 Comparison of the concentration response curves to ATPgammaS with those for ATP and adenosine, at different incubation times, indicated that the response to purine nucleotides was not wholly dependent on conversion to adenosine. Adenosine deaminase abolished the response to adenosine but only reduced the response to ATP by about 50%. These results suggest the participation of a receptor responsive to nucleotides. 4 Isobutylmethylxanthine and 8-sulphophenyltheophylline prevented the cyclic AMP response, while neither 8-cyclopentyl-1, 3-dipropylxanthine nor SCH58261 were effective antagonists. 2-chloradenosine gave a robust response, but neither 2-chloro-N6-cyclopentyladenosine nor CGS 21680 were agonists. 5 These results show that adenosine and ATP can elevate the cyclic AMP levels of brain endothelial cells by acting on receptors which have a pharmacology apparently distinct from known P2Y and adenosine receptors.

Indexed as

AdenosineAdenosine TriphosphateAdenylyl Cyclase InhibitorsAnimalsBrainCapillariesCells, CulturedCerebrovascular CirculationColforsinCyclic AMPCyclooxygenase InhibitorsEndothelium, VascularPhosphodiesterase InhibitorsPurinergic P1 Receptor AgonistsPurinergic P1 Receptor AntagonistsRatsAdenosineAdenosine TriphosphateAdenylyl Cyclase InhibitorsColforsinCyclic AMPCyclooxygenase InhibitorsP2ry1 protein, ratP2ry2 protein, ratPhosphodiesterase InhibitorsPurinergic P1 Receptor AgonistsPurinergic P1 Receptor Antagonistspurinoceptor P2Y4purinoceptor P2Y6Receptors, Purinergic P2Receptors, Purinergic P2Y1Receptors, Purinergic P2Y2

Identifiers

PMID10510459
PMCPMC1571638
OpenAlexW2094046861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.